Related Experiment Video
Updated: Oct 20, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.0K
Cardiovascular disease in SARS-CoV-2 infection
Kei Sato1,2, Jane E Sinclair3, Habib Sadeghirad4
1Critical Care Research Group The Prince Charles Hospital Brisbane QLD Australia.
Clinical & Translational Immunology
|September 13, 2021
Summary
COVID-19 (SARS-CoV-2) can cause new cardiovascular disease and worsen existing conditions. This review examines acute and long-term heart problems, aiding in identifying at-risk patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Pre-existing cardiovascular disease (CVD) is a major risk factor for severe COVID-19 outcomes.
- SARS-CoV-2 infection can precipitate new-onset acute and chronic cardiovascular conditions.
- Understanding these effects is crucial for patient management and prognosis.
Purpose of the Study:
- To review the current evidence on acute and long-term cardiovascular consequences of SARS-CoV-2 infection.
- To explore the mechanisms by which SARS-CoV-2 impacts cardiovascular health.
- To identify risk factors for long-term cardiovascular disease post-infection.
Main Methods:
- Literature review of studies on COVID-19 and cardiovascular disease.
- Analysis of reported acute cardiac complications (arrhythmia, myocarditis, heart failure).
- Assessment of potential long-term cardiovascular sequelae (hypertension, atherosclerosis).
Main Results:
- Acute cardiac complications are linked to increased in-hospital mortality.
- Mechanisms include direct viral damage and systemic inflammation.
- Long-term effects like hypertension and heart failure are emerging but require further characterization.
- Risk factors for long-term CVD are not well-defined.
Conclusions:
- SARS-CoV-2 poses significant risks for both acute and chronic cardiovascular disease.
- Further research is needed to elucidate long-term impacts and identify high-risk individuals.
- Targeted follow-up strategies are essential for patients experiencing cardiovascular complications after COVID-19.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
94
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
94
01:30Coronary Artery Disease III: Clinical Manifestations
80
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
80
01:30Cardiomyopathy II: Dilated Cardiomyopathy
79
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
79
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
117
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
117
01:30Coronary Artery Disease I: Introduction
510
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
510
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
84
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
84